Health Care·Pharmaceuticals·$119.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +5.02% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.46 | N/A | +5.02% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting the importance of their ongoing projects. They emphasized a commitment to maintaining operational efficiency.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering value through our pipeline.
Bristol Myers Squibb's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell 1.55% on the day, likely due to the lack of revenue data and forward guidance, leaving investors uncertain about future performance. The cautious tone from management may have also contributed to the stock's decline.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CROWN CASTLE INC REI REIT
Oct 21, 2013